Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 23.415
Filtrer
1.
Sci Rep ; 14(1): 15273, 2024 07 03.
Article de Anglais | MEDLINE | ID: mdl-38961109

RÉSUMÉ

Imbalances in electrolyte concentrations can have severe consequences, but accurate and accessible measurements could improve patient outcomes. The current measurement method based on blood tests is accurate but invasive and time-consuming and is often unavailable for example in remote locations or an ambulance setting. In this paper, we explore the use of deep neural networks (DNNs) for regression tasks to accurately predict continuous electrolyte concentrations from electrocardiograms (ECGs), a quick and widely adopted tool. We analyze our DNN models on a novel dataset of over 290,000 ECGs across four major electrolytes and compare their performance with traditional machine learning models. For improved understanding, we also study the full spectrum from continuous predictions to a binary classification of extreme concentration levels. Finally, we investigate probabilistic regression approaches and explore uncertainty estimates for enhanced clinical usefulness. Our results show that DNNs outperform traditional models but model performance varies significantly across different electrolytes. While discretization leads to good classification performance, it does not address the original problem of continuous concentration level prediction. Probabilistic regression has practical potential, but our uncertainty estimates are not perfectly calibrated. Our study is therefore a first step towards developing an accurate and reliable ECG-based method for electrolyte concentration level prediction-a method with high potential impact within multiple clinical scenarios.


Sujet(s)
Électrocardiographie , Électrolytes , Électrocardiographie/méthodes , Humains , Électrolytes/sang , , Analyse de régression , Apprentissage machine
2.
J Cardiothorac Surg ; 19(1): 356, 2024 Jun 22.
Article de Anglais | MEDLINE | ID: mdl-38909234

RÉSUMÉ

OBJECTIVE: Systematic evaluation of the safety of del Nido cardioplegia compared to cold blood cardioplegia in adult cardiac surgery. METHODS: We systematically searched PubMed, EMbase, The Cochrane Library and ClinicalTrials.gov for randomized clinical trials (published by 14 January 2024) comparing del Nido cardioplegia to cold blood cardioplegia in adult. Our main endpoints were myocardial injury markers and clinical outcomes. We assessed pooled data by use of a random-effects model or a fixed-effects model. RESULTS: A total of 10 studies were identified, incorporating 889 patients who received del Nido cardioplegia and 907 patients who received cold blood cardioplegia. The meta-analysis results showed that compared with the cold blood cardioplegia, the del Nido cardioplegia had less volume of cardioplegia, higher rate of spontaneous rhythm recovery after cross clamp release, lower levels of postoperative cardiac troponin T and creatinine kinase-myocardial band, all of which were statistically significant. However, there was no statistically significant difference in postoperative troponin I and postoperative left ventricular ejection fraction. The clinical outcomes including mechanical ventilation time, intensive care unit stay time, hospital stay time, postoperative stroke, postoperative new-onset atrial fibrillation, postoperative heart failure requiring intra-aortic balloon pump mechanical circulation support, and in-hospital mortality of both are comparable. CONCLUSION: Existing evidence suggests that del Nido cardioplegia reduced volume of cardioplegia administration and attempts of defibrillation. The superior postoperative results in CTnT and CK-MB may provide a direction for further research on improvement of the composition of cardioplegia.


Sujet(s)
Procédures de chirurgie cardiaque , Solutions cardioplégiques , Arrêt cardiaque provoqué , Essais contrôlés randomisés comme sujet , Humains , Arrêt cardiaque provoqué/méthodes , Procédures de chirurgie cardiaque/méthodes , Solutions cardioplégiques/usage thérapeutique , Adulte , Chlorure de potassium , Mannitol , Lidocaïne , Solutions , Électrolytes , Sulfate de magnésium , Hydrogénocarbonate de sodium
3.
Int J Biol Macromol ; 273(Pt 1): 132993, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38862049

RÉSUMÉ

Low ionic conductivity and poor interface stability of poly(ethylene oxide) (PEO) restrict the practical application as polymeric electrolyte films to prepare solid-state lithium (Li) metal batteries. In this work, biomass-based carboxymethyl chitosan (CMCS) is designed and developed as organic fillers into PEO matrix to form composite electrolytes (PEO@CMCS). Carboxymethyl groups of CMCS fillers can promote the decomposition of Lithium bis(trifluoromethane sulfonimide) (LiTFSI) to generate more lithium fluoride (LiF) at CMCS/PEO interface, which not only forms ionic conductive network to promote the rapid transfer of Li+ but also effectively enhances the interface stability between polymeric electrolyte and Li metal. The enrichment of carboxyl, hydroxyl, and amidogen functional groups within CMCS fillers can form hydrogen bonds with ethylene oxide (EO) chains to improve the tensile properties of PEO-based electrolyte. In addition, the high hardness of CMCS additives can also strengthen mechanical properties of PEO-based electrolyte to resist penetration of Li dendrites. LiLi symmetric batteries can achieve stable cycle for 2500 h and lithium iron phosphate full batteries can maintain 135.5 mAh g-1 after 400 cycles. This work provides a strategy for the enhancement of ion conductivity and interface stability of PEO-based electrolyte, as well as realizes the resource utilization of biomass-based CMCS.


Sujet(s)
Chitosane , Conductivité électrique , Alimentations électriques , Électrolytes , Lithium , Polyéthylène glycols , Chitosane/composition chimique , Chitosane/analogues et dérivés , Polyéthylène glycols/composition chimique , Lithium/composition chimique , Électrolytes/composition chimique , Ions/composition chimique
4.
Int J Biol Macromol ; 273(Pt 2): 133203, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38885860

RÉSUMÉ

This study investigates the performance of biopolymer electrolytes based on chitosan and dextran for energy storage applications. The optimization of ion transport and performance of electric double-layer capacitors EDCL using these electrolytes, incorporating different concentrations of glycerol as a plasticizer and TiO2 as nanoparticles, is explored. Impedance measurements indicate a notable reduction in charge transfer resistance with the addition of TiO2. DC conductivity estimates from AC spectra plateau regions reach up to 5.6 × 10-4 S/cm. The electric bulk resistance Rb obtained from the Nyquist plots exhibits a substantial decrease with increasing plasticizer concentration, further enhanced by the addition of the nanoparticles. Specifically, Rb decreases from ∼20 kΩ to 287 Ω when glycerol concentration increases from 10 % to 40 % and further drops to 30 Ω with the introduction of TiO2. Specific capacitance obtained from cyclic voltammetry shows a notable increase as the scan rate decreases, indicating improved efficiency and stability of ion transport. The TiO2-enriched EDCL achieves 12.3 F/g specific capacitance at 20 mV/s scan rate, with high ion conductivity and extended electrochemical stability. These results suggest the great potential of plasticizer and TiO2 with biopolymers in improving the performance of energy storage systems.


Sujet(s)
Chitosane , Dextrane , Électrolytes , Transport des ions , Titane , Titane/composition chimique , Chitosane/composition chimique , Électrolytes/composition chimique , Dextrane/composition chimique , Capacité électrique , Conductivité électrique , Plastifiants/composition chimique
5.
Int J Biol Macromol ; 273(Pt 2): 133204, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38889831

RÉSUMÉ

Herein, the novel eco-friendly biopolymer electrolytes consisting of banana powder and konjac glucomannan host matrix doped with zinc acetate salt were successfully fabricated through simple casting technique. The biopolymer electrolyte exhibited satisfactory thermal stability and mechanical properties; tensile strength (13.82 MPa); elongation at break (60.52 %) and Young's modulus (93.2 MPa). The electrochemical studies were carried out in symmetrical cells Zn/Zn cells. Biopolymer electrolyte showed favorable ionic conductivity of 5.59 × 10-4 S/cm along with stable cycling performance. The potential stability was found to be 2.52 V. The as-prepared biopolymer electrolytes demonstrated the potential as green, simple yet effective biopolymer electrolytes for zinc-ion batteries.


Sujet(s)
Alimentations électriques , Électrolytes , Mannanes , Musa , Poudres , Zinc , Mannanes/composition chimique , Musa/composition chimique , Électrolytes/composition chimique , Zinc/composition chimique , Biopolymères/composition chimique , Ions/composition chimique , Conductivité électrique , Résistance à la traction
6.
Int Ophthalmol ; 44(1): 233, 2024 Jun 17.
Article de Anglais | MEDLINE | ID: mdl-38886282

RÉSUMÉ

PURPOSE: Intraocular irrigating solution is extensively applied in cataract surgery. This paper explored the difference and relationship between optical coherence tomography (OCT) and optical quality analysis system (OQAS) parameters induced by compound electrolyte intraocular irrigating solution (CEIIS) or Ringer lactate (RL) solution during uncomplicated cataract surgery. METHODS: Totally 200 senior cataract patients were randomly divided into the CEIIS and RL groups (N = 100 patients/group). The anterior chamber was irrigated by CEIIS or RL during phacoemulsification. Patients were subdivided into diabetes mellitus (DM)+ and DM- groups. The central macular thickness (CMT), hyper reflective foci (HF), modulation transfer function cutoff frequency (MTF cutoff), Strehl ratio (SR), objective scatter index (OSI), and OQAS values (OVs) at 100%, 20%, and 9% contrast levels were measured preoperatively and 1 day and 1 week after operation using spectral-domain optical coherence tomography and OQAS II, respectively. Best-corrected visual acuity (BCVA) was assessed using the Snellen scale, followed by statistical analysis of its logarithm of the minimal angle of resolution. RESULTS: There were no significant differences in clinical characteristics between the CEIIS and RL groups. Both groups exhibited notably increased postoperative CMT, MTF cutoff, SR, OV at 100%, 20%, and 9% contrast levels, and reduced OSI, indicating CEIIS and RL improved postoperative visual quality. CEIIS surpassed RL solution in improving postoperative visual quality, decelerating the increase of macular HF numbers and CMT in DM+ patients and postoperative BCVA. There was no difference between CEIIS and RL in long-term vision improvement. CONCLUSION: CEIIS surpasses RL in postoperative visual recovery and retards increases of macular HF numbers and CMT in senior DM+ cataract patients.


Sujet(s)
Phacoémulsification , Solution de Ringer au lactate , Tomographie par cohérence optique , Acuité visuelle , Humains , Femelle , Mâle , Sujet âgé , Tomographie par cohérence optique/méthodes , Solution de Ringer au lactate/administration et posologie , Phacoémulsification/méthodes , Adulte d'âge moyen , Irrigation thérapeutique/méthodes , Électrolytes/administration et posologie , Récupération fonctionnelle , Cataracte/complications , Études prospectives , Solutions ophtalmiques/administration et posologie
7.
Nutrients ; 16(11)2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38892699

RÉSUMÉ

BACKGROUND: Maintaining adequate hydration is critical to optimal health, well-being, and performance. Those who are physically active in stressful environments, such as warm and/or humid scenarios, may be at particular risk for dehydration with ensuing loss of electrolytes, leading to sluggishness and impaired physical performance. METHODS: We evaluated an electrolyte and amino acid product containing L-alanine and L-glutamine, as well as select vitamins [B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B12 (cobalamin), and vitamin C (ascorbic acid)]. Subjects (n = 40; four groups, n = 10) were randomized to consume either a placebo packet or one, two, or three packets daily of the test product for 4 weeks with site visits at 0, 2, and 4 weeks. We tested safety and tolerability by analyzing hematological parameters (complete blood counts), metabolic parameters (hepatic, renal, acid-base balance), urinalysis end products, thyroid status [T3 (triiodothyronine), T4 (thyroxine), TSH (thyroid-stimulating hormone)], tolerability (via questionnaire), vital signs, and dietary intake. RESULTS: Statistical analyses displayed ten significant main effects (p < 0.05) with white blood cells, lymphocytes, neutrophils, urinary pH, thyroxine, urination frequency, calcium, calories, fat, and cholesterol. Interactions for time and group (p < 0.05) were observed for MCV, eGFR, potassium, overall tolerability, bloating, and cramping-demonstrating mild GA disturbances. Little to no change of physiological relevance was noted for any outcome variable, regardless of dosing level. CONCLUSIONS: Our results indicate the product was well-tolerated at all dosing levels and no significant adverse changes occurred in any of the test parameters compared to the placebo group, indicating relative safety of ingestion over a 4-week treatment period, at the volumes used, and outside the context of physical stress.


Sujet(s)
Acides aminés , Humains , Femelle , Mâle , Adulte , Acides aminés/sang , Boissons , Jeune adulte , Déshydratation , Méthode en double aveugle , Adulte d'âge moyen , Électrolytes , Vitamines/administration et posologie , Équilibre hydroélectrolytique/effets des médicaments et des substances chimiques
8.
Int J Mol Sci ; 25(11)2024 May 30.
Article de Anglais | MEDLINE | ID: mdl-38892189

RÉSUMÉ

High-temperature polymer-electrolyte membrane fuel cells (HT-PEMFCs) are a very important type of fuel cells since they operate at 150-200 °C, making it possible to use hydrogen contaminated with CO. However, the need to improve the stability and other properties of gas-diffusion electrodes still impedes their distribution. Self-supporting anodes based on carbon nanofibers (CNF) are prepared using the electrospinning method from a polyacrylonitrile solution containing zirconium salt, followed by pyrolysis. After the deposition of Pt nanoparticles on the CNF surface, the composite anodes are obtained. A new self-phosphorylating polybenzimidazole of the 6F family is applied to the Pt/CNF surface to improve the triple-phase boundary, gas transport, and proton conductivity of the anode. This polymer coating ensures a continuous interface between the anode and proton-conducting membrane. The polymer is investigated using CO2 adsorption, TGA, DTA, FTIR, GPC, and gas permeability measurements. The anodes are studied using SEM, HAADF STEM, and CV. The operation of the membrane-electrode assembly in the H2/air HT-PEMFC shows that the application of the new PBI of the 6F family with good gas permeability as a coating for the CNF anodes results in an enhancement of HT-PEMFC performance, reaching 500 mW/cm2 at 1.3 A/cm2 (at 180 °C), compared with the previously studied PBI-O-PhT-P polymer.


Sujet(s)
Benzimidazoles , Électrodes , Benzimidazoles/composition chimique , Polymères/composition chimique , Nanofibres/composition chimique , Alimentations électriques , Membrane artificielle , Électrolytes/composition chimique , Résines acryliques/composition chimique
9.
Lab Chip ; 24(13): 3284-3293, 2024 Jun 25.
Article de Anglais | MEDLINE | ID: mdl-38847194

RÉSUMÉ

The prostate-specific antigen (PSA) test is considered an important way for preoperative diagnosis and accurate screening of prostate cancer. Current antigen detection methods, including radioimmunoassay, enzyme-linked immunosorbent assay and microfluidic electrochemical detection, feature expensive equipment, long testing time and poor stability. Here, we propose a portable biosensor composed of electrolyte-gated amorphous indium gallium zinc oxide (a-IGZO) transistors with an extended gate, which can achieve real-time, instant PSA detection at a low operating voltage (<2 V) owing to the liquid-free ionic conductive elastomer (ICE) serving as the gate dielectric. The electric double layer (EDL) capacitance in ICE enhances the accumulation of carriers in the IGZO channel, leading to strong gate modulation, which enables the IGZO transistor to have a small subthreshold swing (<0.5 V dec-1) and a high on-state current (∼4 × 10-4 A). The separate, biodegradable, and pluggable sensing pad, serving as an extended gate connected to the IGZO transistor, prevents contamination and depletion arising from direct contact with biomolecular buffers, enabling the IGZO transistor to maintain superior electronic performance for at least six months. The threshold voltage and channel current of the transistor exhibit excellent linear response to PSA molecule concentrations across five orders of magnitude ranging from 1 fg mL-1 to 10 pg mL-1, with a detection limit of 400 ag mL-1 and a detection time of ∼5.1 s. The fabricated biosensors offer a point-of-care system for antigen detection, attesting the feasibility of the electrolyte-gated transistors in clinical screening, healthcare diagnostics and biological management.


Sujet(s)
Techniques de biocapteur , Électrolytes , Gallium , Antigène spécifique de la prostate , Transistors électroniques , Oxyde de zinc , Antigène spécifique de la prostate/analyse , Humains , Électrolytes/composition chimique , Oxyde de zinc/composition chimique , Techniques de biocapteur/instrumentation , Gallium/composition chimique , Mâle , Indium/composition chimique , Conception d'appareillage
10.
Environ Sci Technol ; 58(25): 10881-10896, 2024 Jun 25.
Article de Anglais | MEDLINE | ID: mdl-38861036

RÉSUMÉ

One of the most promising approaches to address the global challenge of climate change is electrochemical carbon capture and utilization. Solid electrolytes can play a crucial role in establishing a chemical-free pathway for the electrochemical capture of CO2. Furthermore, they can be applied in electrocatalytic CO2 reduction reactions (CO2RR) to increase carbon utilization, produce high-purity liquid chemicals, and advance hybrid electro-biosystems. This review article begins by covering the fundamentals and processes of electrochemical CO2 capture, emphasizing the advantages of utilizing solid electrolytes. Additionally, it highlights recent advancements in the use of the solid polymer electrolyte or solid electrolyte layer for the CO2RR with multiple functions. The review also explores avenues for future research to fully harness the potential of solid electrolytes, including the integration of CO2 capture and the CO2RR and performance assessment under realistic conditions. Finally, this review discusses future opportunities and challenges, aiming to contribute to the establishment of a green and sustainable society through electrochemical CO2 valorization.


Sujet(s)
Dioxyde de carbone , Électrolytes , Dioxyde de carbone/composition chimique , Électrolytes/composition chimique , Changement climatique , Techniques électrochimiques
11.
J Assoc Physicians India ; 72(6S): 39-56, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38932734

RÉSUMÉ

BACKGROUND: Dehydration is a highly prevalent clinical challenge in adults which can go undetected. Although dehydration is commonly associated with an increased risk of hospitalization and mortality, only a few international guidelines provide recommendations regarding oral fluids, electrolytes, and energy (FEE) management in adults/geriatrics with dehydration due to nondiarrheal causes. Currently, there is a lack of comprehensive recommendations on the role of oral FEE in nondiarrheal dehydration in adult and geriatric Indian patients. MATERIALS AND METHODS: A modified Delphi approach was designed using an online questionnaire-based survey followed by a virtual meeting, and another round of online surveys was used to develop this consensus recommendation. In round one, 130 statements, including 21 open-ended questions, were circulated among ten national experts who were asked to either strongly agree, agree, disagree, or strongly disagree with statements and provide responses to open-ended questions. The consensus was predefined at 75% agreement (pooling "strongly agree" and "agree" responses). Presentation of relevant literature was done during a virtual discussion, and some statements (the ones that did not achieve predefined agreement) were actively discussed and deliberately debated to arrive at conclusive statements. Those statements that did not reach consensus were revised and recirculated during round two. RESULTS: Consensus was achieved for 130/130 statements covering various domains such as assessment of dehydration, dehydration in geriatrics, energy requirement, impact of oral FEE on patient outcome, and fluid recommendations in acute and chronic nondiarrheal illness. However, one statement was not added as a recommendation in the final consensus (129/130) as further literature review did not find any supporting data. Oral FEE should be recommended as part of core treatment from day 1 of acute nondiarrheal illness and started at the earliest feasibility in chronic illnesses for improved patient outcomes. Appropriately formulated fluids with known electrolyte and energy content, quality standards, and improved palatability may further impact patient compliance and could be a good option. CONCLUSION: These consensus recommendations provide guidance for oral FEE recommendations in Indian adult/geriatric patients with various nondiarrheal illnesses.


Sujet(s)
Consensus , Déshydratation , Méthode Delphi , Traitement par apport liquidien , Humains , Déshydratation/thérapie , Déshydratation/étiologie , Traitement par apport liquidien/méthodes , Inde , Sujet âgé , Adulte , Diarrhée/thérapie , Diarrhée/étiologie , Électrolytes/administration et posologie
12.
J Assoc Physicians India ; 72(6S): 7-15, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38932730

RÉSUMÉ

BACKGROUND: Dehydration due to reduced intake or increased losses including insensible losses in patients with acute nondiarrheal diseases may lead to fluid, electrolytes, and energy (FEE) deficits. The impact of oral FEE supplementation adjuvant to standard of care (SOC) treatment on recovery in patients with acute nondiarrheal diseases is yet to be evaluated. AIM: To determine the effectiveness of ORSL® variants (ORSL® Apple Drink and ORSL® PLUS Orange Drink), fruit juice-based electrolyte drinks as an adjuvant along with SOC in the restoration of oral FEE in patients with acute nondiarrheal disease with fever and/or general weakness who attended an outpatient department (OPD). MATERIALS AND METHODS: This was a prospective, interventional, open-label, multicenter, real-world, study conducted at eight sites across India. Patients with fever and/or general weakness due to an acute nondiarrheal illness were given either ORSL® Apple Drink or ORSL® PLUS Orange Drink as an adjuvant along with SOC treatment per physician's discretion. The primary endpoint of the study was to assess improvement from baseline in energy or hydration levels after ORSL® variants consumption at 6, 24, and 48 hours measured by a new aided recovery scale (ARS). Secondary endpoints were to assess the improvement in energy and hydration levels at 20, 40, and 60 minutes, as well as energy levels and hydration levels at 20, 40, and 60 minutes, 6, 24, and 48 hours after the consumption of ORSL® Apple Drink or ORSL® PLUS Orange Drink. The patient's consumption of ORSL® variants and treatment experience, physician's experience of recommending ORSL® variants, and product safety were evaluated. RESULTS: In total, 612 patients were enrolled with mean age 38.3 years, of whom 62.9% were male. The mean baseline level of energy and hydration was 1.59 (range 1.0-2.0) on ARS. Statistically significant (p < 0.0001) improvements were observed in energy or hydration 6 hours after first consumption of ORSL formulations. Furthermore, improvement was observed from 40 minutes, and in levels of energy, hydration, and both energy and hydration from 60 minutes. Patients and physicians reported a positive experience with ORSL® variants. CONCLUSION: ORSL® Apple Drink and ORSL® PLUS Orange Drink are clinically proven to provide hydration and/or energy to patients with fever and/or general weakness.


Sujet(s)
Fièvre , Humains , Mâle , Femelle , Inde , Adulte , Études prospectives , Fièvre/étiologie , Fièvre/thérapie , Adulte d'âge moyen , Déshydratation/étiologie , Déshydratation/thérapie , Traitement par apport liquidien/méthodes , Jus de fruits et de légumes , Jeune adulte , Solutions réhydratation/administration et posologie , Solutions réhydratation/usage thérapeutique , Électrolytes/administration et posologie
13.
J Assoc Physicians India ; 72(6S): 57-66, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38932735

RÉSUMÉ

Acute nondiarrheal illnesses (NDIs) involve overt or subclinical dehydration, requiring rehydration and electrolyte repletion. Dehydration is frequently under-recognized and under-managed, both in outpatient departments (OPDs) and inpatient departments (IPDs). Postadmission dehydration is associated with longer hospital stays and higher inhospital mortality rates. Recognizing and understanding dehydration in hospitalized patients is necessary due to the adverse outcomes associated with this condition. In this article, we aimed to develop practical consensus recommendations on the role of oral fluid, electrolyte, and energy (FEE) management in hospitalized patients with FEE deficits in NDI. The modified Delphi consensus methodology was utilized to reach a consensus. A scientific committee comprising eight experts from India formed the panel. Relevant clinical questions within three major domains were formulated for presentation and discussion: (1) burden and factors contributing to dehydration in hospitalized patients; (2) assessment of fluid and electrolyte losses and increased energy requirements in hospitalized patients; and (3) management of FEE deficits in hospitalized patients [at admission, during intravenous (IV) therapy, IV to oral de-escalation, and discharge]. The consensus level was classified into agreement (mean score ≥4), no consensus (mean score <4), and exclusion (mean score <4 after the third round of discussion). The questions that lacked agreement were discussed during the virtual meeting. The experts agreed that the most common factors contributing to dehydration in patients with NDI hospitalized in IPDs include decreased oral fluid intake, increased fluid loss due to the illness, insensible fluid loss, and a lack of awareness among doctors about dehydration, which can result in poor fluid intake. Time constraints, discontinuity of care, lack of awareness of the principles of fluid balance, lack of formal procedures for enforcing hydration schemes, and lack of adequate training are most often barriers to the assessment of hydration status in hospital settings. Experts used hydration biomarkers, such as changes in body weight, serum, or plasma osmolality; fluid intake; and fluid balance charts; along with urine output, frequency, quantity, and color, to determine hydration status in hospital settings. Experts agreed that appropriate FEE supplementation in the form of ready-to-drink (RTD) fluids can restore FEE deficits and shorten the length of hospital stays in hospitalized patients at admission, during de-escalation from IV to oral therapy, and at discharge. RTD electrolyte solutions with known concentrations of electrolytes and energy are good choices to avoid taste fatigue and replenish FEE in hospitalized patients during transition care and at discharge.


Sujet(s)
Déshydratation , Traitement par apport liquidien , Hospitalisation , Humains , Traitement par apport liquidien/méthodes , Inde , Déshydratation/thérapie , Déshydratation/étiologie , Sortie du patient , Électrolytes/administration et posologie , Consensus , Méthode Delphi
14.
Diabetes Metab Res Rev ; 40(5): e3831, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38925619

RÉSUMÉ

Fluid resuscitation during diabetic ketoacidosis (DKA) is most frequently performed with 0.9% saline despite its high chloride and sodium concentration. Balanced Electrolyte Solutions (BES) may prove a more physiological alternative, but convincing evidence is missing. We aimed to compare the efficacy of 0.9% saline to BES in DKA management. MEDLINE, Cochrane Library, and Embase databases were searched for relevant studies using predefined keywords (from inception to 27 November 2021). Relevant studies were those in which 0.9% saline (Saline-group) was compared to BES (BES-group) in adults admitted with DKA. Two reviewers independently extracted data and assessed the risk of bias. The primary outcome was time to DKA resolution (defined by each study individually), while the main secondary outcomes were changes in laboratory values, duration of insulin infusion, and mortality. We included seven randomized controlled trials and three observational studies with 1006 participants. The primary outcome was reported for 316 patients, and we found that BES resolves DKA faster than 0.9% saline with a mean difference (MD) of -5.36 [95% CI: -10.46, -0.26] hours. Post-resuscitation chloride (MD: -4.26 [-6.97, -1.54] mmoL/L) and sodium (MD: -1.38 [-2.14, -0.62] mmoL/L) levels were significantly lower. In contrast, levels of post-resuscitation bicarbonate (MD: 1.82 [0.75, 2.89] mmoL/L) were significantly elevated in the BES-group compared to the Saline-group. There was no statistically significant difference between the groups regarding the duration of parenteral insulin administration (MD: 0.16 [-3.03, 3.35] hours) or mortality (OR: -0.67 [0.12, 3.68]). Studies showed some concern or a high risk of bias, and the level of evidence for most outcomes was low. This meta-analysis indicates that the use of BES resolves DKA faster than 0.9% saline. Therefore, DKA guidelines should consider BES instead of 0.9% saline as the first choice during fluid resuscitation.


Sujet(s)
Acidocétose diabétique , Traitement par apport liquidien , Solution physiologique salée , Adulte , Humains , Acidocétose diabétique/thérapie , Acidocétose diabétique/traitement médicamenteux , Électrolytes/administration et posologie , Traitement par apport liquidien/méthodes , Pronostic , Réanimation/méthodes , Solution physiologique salée/administration et posologie
15.
Biosens Bioelectron ; 261: 116444, 2024 Oct 01.
Article de Anglais | MEDLINE | ID: mdl-38850740

RÉSUMÉ

Electrolyte-gated organic synaptic transistors (EGOSTs) can have versatile synaptic plasticity in a single device, so they are promising as components of neuromorphic implants that are intended for use in neuroprosthetic electronic nerves that are energy-efficient and have simple system structure. With the advancement in transistor properties of EGOSTs, the commercialization of neuromorphic implants for practical long-term use requires consistent operation, so they must be stable in vivo. This requirement demands strategies that maintain electronic and ionic transport in the devices while implanted in the human body, and that are mechanically, environmentally, and operationally stable. Here, we cover the structure, working mechanisms, and electrical responses of EGOSTs. We then focus on strategies to ensure their stability to maintain these characteristics and prevent adverse effects on biological tissues. We also highlight state-of-the-art neuromorphic implants that incorporate these strategies. We conclude by presenting a perspective on improvements that are needed in EGOSTs to develop practical, neuromorphic implants that are long-term useable.


Sujet(s)
Techniques de biocapteur , Électrolytes , Transistors électroniques , Humains , Techniques de biocapteur/instrumentation , Électrolytes/composition chimique , Prothèses et implants , Conception d'appareillage , Plasticité neuronale , Synapses/physiologie , Animaux
16.
Clin Transl Gastroenterol ; 15(6): e1, 2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38713137

RÉSUMÉ

INTRODUCTION: Constipation is an independent risk factor for poor bowel preparation. This study aimed to evaluate the bowel cleansing efficacy and safety of polyethylene glycol (PEG) combined with linaclotide (lin) for colonoscopy in patients with chronic constipation (CC). METHODS: This single-blinded, randomized, controlled, and multicenter study was conducted from July 2021 to December 2022 at 7 hospitals. Patients with CC who underwent colonoscopies were enrolled and randomly assigned to 4 groups with split-PEG regimens: 4L-PEG group, 4L-PEG+1d-Lin group, 3L-PEG+1d-Lin group, and 3L-PEG+3d-Lin group. The primary outcome was rates of adequate bowel preparation, defined as a total BBPS score ≥6 and a score ≥2 for each segment. Secondary outcomes were adverse effects, sleep quality, willingness to repeat the colonoscopy, adenoma detection rate, and polyp detection rate. RESULTS: Five hundred two patients were enrolled. The rates of adequate bowel preparation (80.0% vs 60.3%, P < 0.001; 84.4% vs 60.3%, P < 0.001) and the total Boston Bowel Preparation Scale (BBPS) scores (6.90 ± 1.28 vs 6.00 ± 1.61, P < 0.001; 7.03 ± 1.24 vs 6.00 ± 1.61, P < 0.01) in the 4L-PEG+1d-Lin group and the 3L-PEG+3d-Lin group were superior to that in the 4L-PEG group. Compared with the 4L-PEG group, the 4L-PEG+1d-Lin group (66.7% vs 81.7%, P = 0.008) and the 3L-PEG+3d-Lin group (75.0% vs 81.7%, P = 0.224) had a lower percentage of mild adverse events. No statistically significant difference in willingness to repeat the colonoscopy, sleep quality, polyp detection rate, or adenoma detection rate was observed among groups. DISCUSSION: PEG combined with linaclotide might be an effective method for bowel preparation before colonoscopy in patients with CC.


Sujet(s)
Cathartiques , Coloscopie , Constipation , Polyéthylène glycols , Humains , Polyéthylène glycols/administration et posologie , Polyéthylène glycols/effets indésirables , Mâle , Femelle , Constipation/diagnostic , Adulte d'âge moyen , Méthode en simple aveugle , Cathartiques/administration et posologie , Cathartiques/effets indésirables , Maladie chronique , Sujet âgé , Adulte , Peptides/administration et posologie , Peptides/effets indésirables , Poudres , Résultat thérapeutique , Électrolytes/administration et posologie , Électrolytes/effets indésirables
17.
ACS Nano ; 18(20): 12808-12819, 2024 May 21.
Article de Anglais | MEDLINE | ID: mdl-38717026

RÉSUMÉ

Considerable progress has already been made in sweat sensors based on electrochemical methods to realize real-time monitoring of biomarkers. However, realizing long-term monitoring of multiple targets at the atomic level remains extremely challenging, in terms of designing stable solid contact (SC) interfaces and fully integrating multiple modules for large-scale applications of sweat sensors. Herein, a fully integrated wristwatch was designed using mass-manufactured sensor arrays based on hierarchical multilayer-pore cross-linked N-doped porous carbon coated by reduced graphene oxide (NPCs@rGO-950) microspheres with high hydrophobicity as core SC, and highly selective monitoring simultaneously for K+, Na+, and Ca2+ ions in human sweat was achieved, exhibiting near-Nernst responses almost without forming an interfacial water layer. Combined with computed tomography, solid-solid interface potential diffusion simulation results reveal extremely low interface diffusion potential and high interface capacitance (598 µF), ensuring the excellent potential stability, reversibility, repeatability, and selectivity of sensor arrays. The developed highly integrated-multiplexed wristwatch with multiple modules, including SC, sensor array, microfluidic chip, signal transduction, signal processing, and data visualization, achieved reliable real-time monitoring for K+, Na+, and Ca2+ ion concentrations in sweat. Ingenious material design, scalable sensor fabrication, and electrical integration of multimodule wearables lay the foundation for developing reliable sweat-sensing systems for health monitoring.


Sujet(s)
Sueur , Dispositifs électroniques portables , Poignet , Sueur/composition chimique , Facteurs temps , Électrolytes/analyse , Graphite/composition chimique , Porosité , Carbone/composition chimique , Cations/composition chimique , Humains , Surveillance biologique/instrumentation
18.
Macromol Rapid Commun ; 45(13): e2300736, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38697133

RÉSUMÉ

Electrochromic devices built with ionogel electrolytes are seen as a pivotal step toward the future of quasi-solid electrochromic devices, due to their striking properties like exceptional safety and high ionic conductivity. Yet, the poor mechanical strength of electrolyte of these devices remains a constraint that hampers their advancement. As a resolution, this research explores the use of a robust, transparent ionogel electrolyte, which is designed using an in situ microphase separation strategy. The ionogels are highly transparent and robust and exhibit excellent physicochemical stability, including a wide electrochemical window and high temperature tolerance. Benefitting from these properties, a high-performance electrochromic device is fabricated through in situ polymerization with the ionogels, PPRODOT as the electrochromic layer, and PEDOT: PSS as the ion storage layer, achieving high transmittance contrast (43.1%), fast response (1/1.7 s), high coloring efficiency (1296.4 cm2 C-1), and excellent cycling endurance (>99.9% retention after 2000 cycles). In addition, using ITO-poly(ethylene terephthalate) as flexible substrates, a deformable electrochromic device displaying high stability is realized, highlighting the potential use in functional wearables.


Sujet(s)
Électrolytes , Gels , Polymérisation , Électrolytes/composition chimique , Gels/composition chimique , Techniques électrochimiques , Polymères/composition chimique , Conductivité électrique
19.
Article de Anglais | MEDLINE | ID: mdl-38696695

RÉSUMÉ

OBJECTIVE: To describe the successful conservative management of chemical pneumonitis and presumed acute respiratory distress syndrome in a cat secondary to inadvertent pulmonary polyethylene glycol-electrolyte solution (PEG-ELS) instillation. CASE SUMMARY: PEG-ELS is commonly used in small animals for bowel cleansing and to treat constipation. There have been several instances of aspiration or accidental instillation of this solution into the lungs of both people and dogs. PEG-ELS was inadvertently infused into the lungs of the cat in the current report. After 10 days in the ICU, during which time treatment with oxygen therapy, antibiosis, diuretics, and corticosteroids was provided, the cat was successfully discharged. NEW OR UNIQUE INFORMATION PROVIDED: To the authors' knowledge, this is the first report of instillation of PEG-ELS in a cat resulting in chemical pneumonitis and lung injury. We describe the successful management of this condition with conservative management and without the need for invasive interventions such as bronchoscopy and lavage or mechanical ventilation.


Sujet(s)
Maladies des chats , Polyéthylène glycols , Chats , Animaux , Polyéthylène glycols/effets indésirables , Polyéthylène glycols/administration et posologie , Maladies des chats/induit chimiquement , Maladies des chats/thérapie , Électrolytes/administration et posologie , Électrolytes/usage thérapeutique , Pneumopathie infectieuse/médecine vétérinaire , Pneumopathie infectieuse/induit chimiquement , Pneumopathie infectieuse/thérapie , Mâle , Femelle
20.
Medicine (Baltimore) ; 103(20): e37749, 2024 May 17.
Article de Anglais | MEDLINE | ID: mdl-38758907

RÉSUMÉ

There are multiple mechanisms by which The Coronavirus-19 (COVID-19) infection can cause electrolyte abnormalities, which may not be the case for bacterial causes of pneumonia. This study aimed to assess the differences in electrolyte levels between patients suffering from COVID-19 and bacterial pneumonia. This is an original, retrospective study. Two cohorts of hospitalized patients were included, 1 suffering from COVID-19 and the other from bacterial pneumonia. Their day 1 and day 3 levels of sodium, potassium, magnesium, and phosphorus, as well as their outcomes, were extracted from the charts. Statistical analysis was subsequently performed. Mean admission levels of sodium, potassium, phosphorus, and magnesium were 135.64 ±â€…6.13, 4.38 ±â€…0.69, 3.53 ±â€…0.69, and 2.03 ±â€…0.51, respectively. The mean day 3 levels of these electrolytes were 138.3 ±â€…5.06, 4.18 ±â€…0.59, 3.578 ±â€…0.59, and 2.11 ±â€…0.64, respectively. Patients suffering from bacterial pneumonia were significantly older (N = 219, mean = 64.88 ±â€…15.99) than patients with COVID-19 pneumonia (N = 240, mean = 57.63 ±â€…17.87). Bacterial pneumonia group had significantly higher serum potassium (N = 211, mean = 4.51 ±â€…0.76), and magnesium (N = 115, mean = 2.12 ±â€…0.60) levels compared to COVID-19 group (N = 227, mean = 4.254 ±â€…0.60 for potassium and N = 118, mean = 1.933 ±â€…0.38 for magnesium). Only magnesium was significantly higher among day 3 electrolytes in the bacterial pneumonia group. No significant association between electrolyte levels and outcomes was seen. We found that COVID-19 patients had lower potassium and magnesium levels on admission, possibly due to the effect of COVID-19 on the renin-angiotensin-aldosterone system as well as patient characteristics and management. We did not find enough evidence to recommend using electrolyte levels as a determinator of prognosis, but more research is needed.


Sujet(s)
COVID-19 , Hospitalisation , Magnésium , Pneumopathie bactérienne , Potassium , Troubles de l'équilibre hydroélectrolytique , Humains , COVID-19/complications , COVID-19/sang , Mâle , Femelle , Études rétrospectives , Adulte d'âge moyen , Sujet âgé , Hospitalisation/statistiques et données numériques , Troubles de l'équilibre hydroélectrolytique/épidémiologie , Troubles de l'équilibre hydroélectrolytique/sang , Pneumopathie bactérienne/sang , Pneumopathie bactérienne/complications , Pneumopathie bactérienne/épidémiologie , Potassium/sang , Magnésium/sang , SARS-CoV-2 , Électrolytes/sang , Sodium/sang , Phosphore/sang
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...